The NIAID/DAIT Adjuvant Development Program supports the development of new candidate vaccine adjuvants through immunological characterization studies and lead compound optimization, up to and including IND-enabling studies, all towards licensure for human use. Adjuvants will be studied with currently licensed or new investigational vaccines to protect against infection by NIAID emerging and re-emerging infectious disease pathogens.

Agency
National Institute of Health (NIH)
Type
Research and Development Contracts (N01)
Project #
272201300028C-0-0-1
Application #
8751859
Study Section
Project Start
2013-09-30
Project End
2016-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2013
Total Cost
$5,516,166
Indirect Cost
Name
Nanobio Corporation
Department
Type
DUNS #
177653487
City
Ann Arbor
State
MI
Country
United States
Zip Code
48105